期刊文献+

南阳市耐多药结核(MDR-TB)rpoB基因突变分子特征研究

Molecular analysis of rpoB gene mutation in multidrug- resistant tuberculosis( MDR- TB) isolates from Nanyang
原文传递
导出
摘要 目的研究南阳市耐多药结核菌(MDR-TB)利福平耐药相关的rpoB基因突变分子特征。方法特异性扩增172株MDR-TB rpoB基因耐药决定区(81 bp)并进行基因测序。结果有157株(91.2%)在耐药决定区发生了突变,最常见的三种突变类型是531(TCG-TTG),526(CAC-GAC)和533(CTG-CCG),突变率分别为41.3%,11.6%和10.5%。结论 rpoB基因耐药决定区(81 bp)的基因突变是引起南阳市结核分枝杆菌利福平耐药的主要原因。 Objective To reveal the molecular characteristics of rpoB gene mutation associated with rifampicin resistance in muhidrug - resistant tuberculosis in Nanyang. Methods One hundred and seventy - two muhidrug - resistant tuberculosis ( MDR - TB) strains were involved to amplify the rpoB gene at rifampin resistance determining region(81 bp) by PCR, then the PCR products were sequenced. Results Mutations in the rpoB were identified in 91.2% of the isolates (157/172). Nucleotide substitutions in codons 531, 526, 533 (41.3% , 11.6% and 10.5%, respectively) were the most prevalent mutations. Conclusion Refampin resistance was mainly caused by mutation of the 81 - bp region of rpoB gene in mycobacteria tuberculosis isolates from Nanyang.
作者 满永宏
出处 《中国卫生检验杂志》 北大核心 2013年第17期3447-3448,共2页 Chinese Journal of Health Laboratory Technology
关键词 结核分枝杆菌 利福平耐药 RPOB基因 Mycobacteria tuberculosis Rrifampicin resistance rpoB gene
  • 相关文献

参考文献6

  • 1满永宏,周艳艳.2011年南阳市结核病一线抗结核药物的耐药监测结果分析[J].中国卫生检验杂志,2012,22(7):1704-1705. 被引量:2
  • 2李国利.结核分枝杆菌耐药分子机制及耐药基因检测方法研究进展[J].中国医师杂志,2002,4(4):338-342. 被引量:26
  • 3Elizabeth A. Campbell,Nataliya Korzheva,Arkady Mustaev,Katsuhiko Murakami,Satish Nair,Alex Goldfarb,Seth A. Darst.Structural Mechanism for Rifampicin Inhibition of Bacterial RNA Polymerase[J].Cell.2001(6)
  • 4A Telenti,P Imboden,F Marchesi,T Schmidheini,T Bodm.Direct, automated detection of rifampin-resistant Mycobacterium tuberculosis by polymerase chain reaction and single-strand conformation polymorphism analysis[].Antimicrobial Agents and Chemotherapy.1993
  • 5Markus Heep,Barbara Br,st?tter,Ulrich Rieger,Norbert Lehn,Elvira Richter,Sabine Rüsch-Gerdes,Stefan Niemann.Frequency of rpoB Mutations Inside and Outside the Cluster I Region in Rifampin-Resistant Clinical Mycobacterium tuberculosis Isolates[].Journal of Clinical Microbiology.2001
  • 6Cheruvu Mani,N. Selvakumar,Sujatha Narayanan,P. R. Narayanan.Mutations in the rpoB Gene of Multidrug-Resistant Mycobacterium tuberculosis Clinical Isolates from India[].Journal of Clinical Microbiology.2001

二级参考文献16

  • 1卫生部疾控司.中国结核病防治规划实施工作指南[M].2002,3:22-27.
  • 2世界卫生组织.耐药结核病规划管理指南(2008年紧急修订版)[M].北京:中国疾病预防控制巾心结核病防治临床中心,2008.
  • 3WHO. Anti -Tuberculosis Drug Resistance in the World Third Global Report. Geneva, Switzerland : WHO, 2004.
  • 4朋许丽,杨应周,吴清芳.深圳市结核病-线抗结核药的耐药监测结果分析[J].2010,32(4):204-207.
  • 5Nikolayevsky V, Brown T, Balabanova Y, et al. Detection of muta- tions associated with isoniazid and rifampin resistance in Mycobacteri- um tuberculosis isolates from Samara Region, Russian Federation[ J]. J Clin Microbiol, 2004, 42:498 - 502.
  • 6TelentiA,ImbodenP,MarchexiF ,etal.Detectionofrifampicin-resistanacemutationsinmycobacteriumtuberculosis[].The Lancet.1993
  • 7HeymB,Al zariPM,HonoreN,etal.Missensemutationsinthecatalase-perox idasegene,KatG,areassociatedwithisoniazidresis tanceinMycobacteriumtuberculosis[].Molecular Microbiology.1995
  • 8Sre evatsanS,StockbaverKE,PanX,eta l.EthambutolresistanceinMycobacteriumtuberculosis:criticalroleofe mbBmutations[].Antimicrobial Agents and Chemotherapy.1997
  • 9Su llivanEA,KreiswirthBN,PalumboL,etal.Emergenceoffluoroquinolone-resistanttuberculosisinNewYorkCity[].The Lancet.1995
  • 10KapurV,LiLL,HamrickMR,etal.RapidMyocbacteriumspeciesassignmentandunambiguousidentificationofmutationsassociatedwithantibioticresistanceinMyocbacteriumtuberculosisbyautomatedDNAsequencing[].ArchPatholLabMed.1995

共引文献26

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部